Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies (2022)
- Authors:
- USP affiliated authors: ANDRICOPULO, ADRIANO DEFINI - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC
- Unidade: IFSC
- DOI: 10.1039/D2MD00262K
- Subjects: DOENÇA DE ALZHEIMER; COMPOSTOS HETEROCÍCLICOS; FARMACOCINÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: RSC Medicinal Chemistry
- ISSN: 2632-8682
- Volume/Número/Paginação/Ano: v. 13, n. 12, p. 1644-1656 + supplementary information, Dec. 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
MACHADO, Valkiria et al. Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies. RSC Medicinal Chemistry, v. 13, n. 12, p. 1644-1656 + supplementary information, 2022Tradução . . Disponível em: https://doi.org/10.1039/D2MD00262K. Acesso em: 31 dez. 2025. -
APA
Machado, V., Cenci, A. R., Teixeira, K. F., Sens, L., Tizziani, T., Nunes, R. J., et al. (2022). Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies. RSC Medicinal Chemistry, 13( 12), 1644-1656 + supplementary information. doi:10.1039/D2MD00262K -
NLM
Machado V, Cenci AR, Teixeira KF, Sens L, Tizziani T, Nunes RJ, Ferreira LLG, Yunes RA, Sandjo LP, Andricopulo AD, Oliveira AS. Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies [Internet]. RSC Medicinal Chemistry. 2022 ; 13( 12): 1644-1656 + supplementary information.[citado 2025 dez. 31 ] Available from: https://doi.org/10.1039/D2MD00262K -
Vancouver
Machado V, Cenci AR, Teixeira KF, Sens L, Tizziani T, Nunes RJ, Ferreira LLG, Yunes RA, Sandjo LP, Andricopulo AD, Oliveira AS. Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies [Internet]. RSC Medicinal Chemistry. 2022 ; 13( 12): 1644-1656 + supplementary information.[citado 2025 dez. 31 ] Available from: https://doi.org/10.1039/D2MD00262K - Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation
- 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors
- Saúde e bem-estar
- World chagas disease day and the new road map for neglected tropical diseases. [Editorial]
- Experimental and computational investigations on a series of drug candidates for Chagas disease
- Medicamentos e tratamentos para a Covid-19
- Structure-based drug design
- Cancer estimates in Brazil reveal progress for the most lethal malignancies [Editorial]
- Synthesis and in vitro leishmanicidal activity of novel n-arylspermidine derivatives
- Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies
Informações sobre o DOI: 10.1039/D2MD00262K (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
